Why is Eli Lilly stock climbing today?

Eli Lilly is experiencing a significant stock price increase, drawing attention to its market performance. In a comparative analysis between Eli Lilly and Merck, one company is identified as the superior choice for long-term investors holding through 2030. The current market momentum favors Eli Lilly as it continues to climb, positioning it as a strategic asset compared to its competitor Merck within the pharmaceutical sector for those seeking stability and growth over the next decade.